Illumina, Inc. (ILMN)

132.81 -1.69 (-1.26%) USD  |  NASDAQ  |  Apr 20, 16:00
132.86 +0.05 (+0.04%) After-Hours: 17:54
More

Illumina SG&A Expense (Quarterly) : 310.00M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ILMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Labcorp Holdings, Inc. 538.60M
GeneDx Holdings Corp. 73.96M
Guardant Health, Inc. 204.32M
Natera, Inc. 291.30M
Mettler-Toledo International, Inc. 259.83M